國立虎尾科技大學 |

Mid-size Drugs Based on Peptides and Peptidomimetics = A New Drug Category /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Mid-size Drugs Based on Peptides and Peptidomimetics/ by Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi.
Reminder of title:	A New Drug Category /
Author:	Tamamura, Hirokazu.
other author:	Kobayakawa, Takuya.
Description:	XVII, 100 p. 40 illus., 32 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Medicinal chemistry. -
Online resource:	https://doi.org/10.1007/978-981-10-7691-6
ISBN:	9789811076916

Mid-size Drugs Based on Peptides and Peptidomimetics = A New Drug Category /
Tamamura, Hirokazu.

Mid-size Drugs Based on Peptides and PeptidomimeticsA New Drug Category /[electronic resource] :by Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi. - 1st ed. 2018. - XVII, 100 p. 40 illus., 32 illus. in color.online resource. - SpringerBriefs in Pharmaceutical Science & Drug Development,1864-8118. - SpringerBriefs in Pharmaceutical Science & Drug Development,.

1. Introduction of Mid-Size Drugs and Peptidomimetics -- 2. Chloroalkene Dipeptide Isosteres as Peptidomimetics -- 3. Conformational-restricted Cyclic Peptides -- 4. Peptidomimetics that Mimic Secondary Structures of Peptides -- 5.Peptidomimetics that Mimic Tertiary Structures of Peptides -- 6. Conjugated Compounds Involving Peptides -- 7. Summary and Future Perspectives of Researches on Mid-Size Drugs.

This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry.

ISBN: 9789811076916

Standard No.: 10.1007/978-981-10-7691-6doiSubjects--Topical Terms:

1253747
Medicinal chemistry.

LC Class. No.: RS400-431

Dewey Class. No.: 615.19

Mid-size Drugs Based on Peptides and Peptidomimetics = A New Drug Category /
LDR:02930nam a22003975i 4500 001 992345
003 DE-He213
005 20200630024611.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811076916 $9 978-981-10-7691-6
024 7 $a 10.1007/978-981-10-7691-6 $2 doi
035 $a 978-981-10-7691-6
050 4 $a RS400-431
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 615.19 $2 23
100 1 $a Tamamura, Hirokazu. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1284058
245 1 0 $a Mid-size Drugs Based on Peptides and Peptidomimetics $h [electronic resource] : $b A New Drug Category / $c by Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a XVII, 100 p. 40 illus., 32 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Pharmaceutical Science & Drug Development, $x 1864-8118
505 0 $a 1. Introduction of Mid-Size Drugs and Peptidomimetics -- 2. Chloroalkene Dipeptide Isosteres as Peptidomimetics -- 3. Conformational-restricted Cyclic Peptides -- 4. Peptidomimetics that Mimic Secondary Structures of Peptides -- 5.Peptidomimetics that Mimic Tertiary Structures of Peptides -- 6. Conjugated Compounds Involving Peptides -- 7. Summary and Future Perspectives of Researches on Mid-Size Drugs.
520 $a This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry.
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Organic chemistry. $3 1148722
650 1 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Organic Chemistry. $3 673440
700 1 $a Kobayakawa, Takuya. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1284059
700 1 $a Ohashi, Nami. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1284060
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811076909
776 0 8 $i Printed edition: $z 9789811076923
830 0 $a SpringerBriefs in Pharmaceutical Science & Drug Development, $x 1864-8118 $3 1254821
856 4 0 $u https://doi.org/10.1007/978-981-10-7691-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)